02/12/2025
8:28 AM | FMR LLC (Filed by)
Foghorn Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/03/2025
6:00 AM | Foghorn Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/02/2025
11:15 PM | Foghorn Therapeutics (Filer)
| Form EFFECT | |
01/24/2025
3:11 PM | Foghorn Therapeutics (Issuer)
Rivkin Anna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2025
3:13 PM | Costa Carlos (Reporting)
Foghorn Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2025
3:15 PM | Foghorn Therapeutics (Issuer)
Humer Kristian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2025
3:16 PM | Cardama Alfonso Quintas (Reporting)
Foghorn Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
6:05 AM | Foghorn Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/30/2024
6:54 AM | Foghorn Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/30/2024
6:54 AM | Foghorn Therapeutics (Issuer)
Koppel Adam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
6:04 AM | Foghorn Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for FHTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Foghorn Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
10/10/2024
6:15 AM | Foghorn Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/08/2024
4:44 PM | Foghorn Therapeutics (Subject)
Klarman Family Foundation (Filed by)
| Form SC 13G/A | |
09/24/2024
3:01 PM | Costa Carlos (Reporting)
Foghorn Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2024
5:00 PM | Flynn James E (Filed by)
Foghorn Therapeutics (Subject)
| Form SC 13G | |
09/18/2024
3:01 PM | Costa Carlos (Reporting)
Foghorn Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
3:40 PM | Costa Carlos (Reporting)
Foghorn Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2024
3:00 PM | Bellon Steven F. (Reporting)
Foghorn Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
3:31 PM | Bellon Steven F. (Reporting)
Foghorn Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/08/2024
7:44 AM | Foghorn Therapeutics (Filer)
| Form 424B5 | |
08/08/2024
6:02 AM | Foghorn Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
6:04 AM | Foghorn Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/26/2024
3:04 PM | Foghorn Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2024
8:48 AM | FMR LLC (Filed by)
Foghorn Therapeutics (Subject)
| Form SC 13G/A | |
05/23/2024
6:03 AM | Foghorn Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/20/2024
3:31 PM | Foghorn Therapeutics (Filer)
| Form 424B5 | |
05/20/2024
7:02 AM | Foghorn Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2024
3:54 PM | Foghorn Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2024
6:03 AM | Foghorn Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2024
6:03 AM | Foghorn Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/06/2024
6:03 AM | Foghorn Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/03/2024
7:00 AM | Foghorn Therapeutics (Filer)
| Form DEF 14A | |
05/03/2024
7:01 AM | Foghorn Therapeutics (Filer)
| Form DEFA14A | |
05/03/2024
7:03 AM | Foghorn Therapeutics (Filer)
| Form ARS | |
04/16/2024
6:01 AM | Foghorn Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/09/2024
3:41 PM | Foghorn Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2024
3:19 PM | Cavalie Fanny (Reporting)
Foghorn Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
6:09 AM | Foghorn Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/07/2024
6:11 AM | Foghorn Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free FHTX Stock Alerts